Epigenetic signaling in schizophrenia

Cellular Signalling

Volumn 27, Issue 10, 2015, Pages 2131-2136

  Ibi, Daisuke ^a,c   González Maeso, Javier ^a,b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^c MEIJO UNIVERSITY   (Japan)

Author keywords

Antipsychotics; Epigenetics; Histone deacetylases (HDACs); Histones; Schizophrenia

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; DNA; HISTONE; HISTONE DEACETYLASE 2; HISTONE DEACETYLASE INHIBITOR; NEUROLEPTIC AGENT;

CHROMOSOME DELETION; CHROMOSOME DUPLICATION; COGNITION; COPY NUMBER VARIATION; DNA METHYLATION; DNA MODIFICATION; DRUG EFFICACY; DRUG MECHANISM; DRUG TARGETING; EPIGENETICS; GENE EXPRESSION; GENE SEQUENCE; GENETIC ANALYSIS; GENOTYPE ENVIRONMENT INTERACTION; HEREDITY; HISTONE MODIFICATION; HUMAN; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SCHIZOPHRENIA; ANIMAL; BRAIN; GENETIC EPIGENESIS; GENETICS; METABOLISM; MOLECULARLY TARGETED THERAPY; SIGNAL TRANSDUCTION;

ANIMALS; ANTIPSYCHOTIC AGENTS; BRAIN; DNA METHYLATION; EPIGENESIS, GENETIC; HISTONE DEACETYLASE INHIBITORS; HUMANS; MOLECULAR TARGETED THERAPY; SCHIZOPHRENIA; SIGNAL TRANSDUCTION;

EID: 84939569309     PISSN: 08986568     EISSN: 18733913     Source Type: Journal    
DOI: 10.1016/j.cellsig.2015.06.003     Document Type: Review

References (125)

1. Freedman R. N. Engl. J. Med. 2003, 349(18):1738-1749.
2. Adam D. Nature 2013, 496:416-418.
3. Sawa A., Snyder S.H. Science 2002, 296(5568):692-695.
4. van Os J., Kapur S. Lancet 2009, 374(9690):635-645. (2009/08/25).
5. Tamminga C.A., Holcomb H.H. Mol. Psychiatry 2005, 10(1):27-39.
6. Minzenberg M.J., Carter C.S. Trends Cogn. Sci. 2012, 16(1):35-42. (2011/12/20).
7. Barch D.M., Ceaser A. Trends Cogn. Sci. 2012, 16(1):27-34. (2011/12/16).
8. Ibrahim H.M., Tamminga C.A. Curr. Pharm. Biotechnol. 2012, 13(8):1587-1594. (2012/01/31).
9. Gray J.A., Roth B.L. Schizophr. Bull. 2007, 33(5):1100-1119.
10. Meltzer H.Y. Annu. Rev. Med. 2013, 64:393-406. (2012/10/02).
11. Lieberman J.A., Bymaster F.P., Meltzer H.Y., Deutch A.Y., Duncan G.E., Marx C.E., et al. Pharmacol. Rev. 2008, 60(3):358-403. (2008/10/17).
12. Lieberman J.A., Stroup T.S., McEvoy J.P., Swartz M.S., Rosenheck R.A., Perkins D.O., et al. N. Engl. J. Med. 2005, 353(12):1209-1223. (2005/09/21).
13. Ibrahim H.M., Tamminga C.A. Annu. Rev. Pharmacol. Toxicol. 2011, 51:189-209. (2010/09/28).
14. Miyamoto S., Miyake N., Jarskog L.F., Fleischhacker W.W., Lieberman J.A. Mol. Psychiatry 2012, 17:1206-1227. (2012/05/16).
15. Lehmann H.E., Hanrahan G.E. A.M.A. Arch. Neurol. Psychiatry 1954, 71(2):227-237.
16. Granger B., Albu S. Ann. Clin. Psychiatry 2005, 17(3):137-140.
17. Crilly J. Hist. Psychiatry 2007, 18(1):30-60.
18. Hippius H. J. Clin. Psychiatry 1999, 60(Suppl. 12):22-23.
19. Roth B.L., Sheffler D.J., Kroeze W.K. Nat. Rev. Drug Discov. 2004, 3(4):353-359. (2004/04/03).
20. Husa A.P., Rannikko I., Moilanen J., Haapea M., Murray G.K., Barnett J., et al. Schizophr. Res. 2014, 158(1-3):134-141. (2014/07/19).
21. Nielsen R.E., Levander S., Kjaersdam Telleus G., Jensen S.O., Christensen T.Ostergaard, Leucht S. Acta Psychiatr. Scand. 2015, 131:185-196. (2015/01/20).
22. Goldberg T.E., Greenberg R.D., Griffin S.J., Gold J.M., Kleinman J.E., Pickar D., et al. Br. J. Psychiatry 1993, 162:43-48. (1993/01/01).
23. Lee S.M., Chou Y.H., Li M.H., Wan F.J., Yen M.H. Prog. Neuropsychopharmacol. Biol. Psychiatry 2007, 31(5):1101-1107. (2007/05/04).
24. Beuzen J.N., Taylor N., Wesnes K., Wood A. J. Psychopharmacol. 1999, 13(2):152-158. (1999/09/04).
25. Akbarian S., Huang H.S. Biol. Psychiatry 2009, 65(3):198-203. (2008/09/26).
26. Berger S.L. Nature 2007, 447(7143):407-412. (2007/05/25).
27. Borrelli E., Nestler E.J., Allis C.D., Sassone-Corsi P. Neuron 2008, 60(6):961-974. (2008/12/27).
28. Dulac C. Nature 2010, 465(7299):728-735. (2010/06/11).
29. Ptak C., Petronis A. Annu. Rev. Pharmacol. Toxicol. 2008, 48:257-276. (2007/09/22).
30. Tsankova N., Renthal W., Kumar A., Nestler E.J. Nat. Rev. Neurosci. 2007, 8(5):355-367. (2007/04/25).
31. Jakovcevski M., Akbarian S. Nat. Med. 2012, 18(8):1194-1204. (2012/08/08).
32. Bhaumik S.R., Smith E., Shilatifard A. Nat. Struct. Mol. Biol. 2007, 14(11):1008-1016. (2007/11/07).
33. Stefansson H., Rujescu D., Cichon S., Pietilainen O.P., Ingason A., Steinberg S., et al. Nature 2008, 455(7210):232-236.
34. Stefansson H., Ophoff R.A., Steinberg S., Andreassen O.A., Cichon S., Rujescu D., et al. Nature 2009, 460(7256):744-747. (2009/07/03).
35. Purcell S.M., Wray N.R., Stone J.L., Visscher P.M., O'Donovan M.C., Sullivan P.F., et al. Nature 2009, 460(7256):748-752. (2009/07/03).
36. Walsh T., McClellan J.M., McCarthy S.E., Addington A.M., Pierce S.B., Cooper G.M., et al. Science 2008, 320(5875):539-543.
37. T.I.S.Consortium Nature 2008, 455(7210):237-241.
38. S.W.G.o.t.P.G.Consortium Nature 2014, 511:421-427. (2014/07/25).
39. Purcell S.M., Moran J.L., Fromer M., Ruderfer D., Solovieff N., Roussos P., et al. Nature 2014, 506(7487):185-190. (2014/01/28).
40. Lewis D.A., Levitt P. Annu. Rev. Neurosci. 2002, 25:409-432. (2002/06/08).
41. Cardno A.G., Gottesman I.I. Am. J. Med. Genet. 2000, 97(1):12-17. (2000/05/17).
42. Gottesman I.I., Erlenmeyer-Kimling L. Schizophr. Res. 2001, 51(1):93-102. (2001/08/02).
43. Brown A.S., Begg M.D., Gravenstein S., Schaefer C.A., Wyatt R.J., Bresnahan M., et al. Arch. Gen. Psychiatry 2004, 61(8):774-780. (2004/08/04).
44. Menninger K.A. J. Am. Med. Assoc. 1919, 72(4):235-241.
45. Yudofsky S.C. JAMA 2009, 301(3):324-326. (2009/01/22).
46. Brown A.S., Cohen P., Harkavy-Friedman J., Babulas V., Malaspina D., Gorman J.M., et al. Biol. Psychiatry 2001, 49(6):473-486. (2001/03/21).
47. Sorensen H.J., Mortensen E.L., Reinisch J.M., Mednick S.A. Schizophr. Bull. 2009, 35(3):631-637. (2008/10/04).
48. Brown A.S., Schaefer C.A., Quesenberry C.P., Liu L., Babulas V.P., Susser E.S. Am. J. Psychiatry 2005, 162(4):767-773. (2005/04/01).
49. Tumpey T.M., Basler C.F., Aguilar P.V., Zeng H., Solorzano A., Swayne D.E., et al. Science 2005, 310(5745):77-80. (2005/10/08).
50. van Os J., Selten J.P. Br. J. Psychiatry 1998, 172:324-326. (1998/08/26).
51. Malaspina D., Corcoran C., Kleinhaus K.R., Perrin M.C., Fennig S., Nahon D., et al. BMC Psychiatry 2008, 8:71. (2008/08/23).
52. Susser E., Clair D.St, He L. Ann. N. Y. Acad. Sci. 2008, 1136:185-192. (2008/06/27).
53. Khashan A.S., Abel K.M., McNamee R., Pedersen M.G., Webb R.T., Baker P.N., et al. Arch. Gen. Psychiatry 2008, 65(2):146-152. (2008/02/06).
54. Brown A.S., Derkits E.J. Am. J. Psychiatry 2010, 167(3):261-280. (2010/02/04).
55. Asp L., Beraki S., Aronsson F., Rosvall L., Ogren S.O., Kristensson K., et al. Neuroreport 2005, 16(10):1111-1115. (2005/06/24).
56. Shi L., Fatemi S.H., Sidwell R.W., Patterson P.H. J. Neurosci. 2003, 23(1):297-302. (2003/01/07).
57. Malkova N.V., Gallagher J.J., Yu C.Z., Jacobs R.E., Patterson P.H. Proc. Natl. Acad. Sci. U. S. A. 2014, 111(24):E2492-E2500. (2014/06/04).
58. Fatemi S.H., Emamian E.S., Sidwell R.W., Kist D.A., Stary J.M., Earle J.A., et al. Mol. Psychiatry 2002, 7(6):633-640. (2002/07/26).
59. Fatemi S.H., Earle J., Kanodia R., Kist D., Emamian E.S., Patterson P.H., et al. Cell. Mol. Neurobiol. 2002, 22(1):25-33. (2002/06/18).
60. Fatemi S.H., Reutiman T.J., Folsom T.D., Huang H., Oishi K., Mori S., et al. Schizophr. Res. 2008, 99(1-3):56-70. (2008/02/06).
61. Pankevich D.E., Mueller B.R., Brockel B., Bale T.L. Physiol. Behav. 2009, 98(1-2):94-102. (2009/04/28).
62. Lemaire V., Koehl M., Le Moal M., Abrous D.N. Proc. Natl. Acad. Sci. U. S. A. 2000, 97(20):11032-11037. (2000/09/27).
63. van den Hove D.L., Jakob S.B., Schraut K.G., Kenis G., Schmitt A.G., Kneitz S., et al. PLoS ONE 2011, 6(8):e22715. (2011/08/23).
64. Koenig J.I., Elmer G.I., Shepard P.D., Lee P.R., Mayo C., Joy B., et al. Behav. Brain Res. 2005, 156(2):251-261. (2004/12/08).
65. Brown A.S., Hooton J., Schaefer C.A., Zhang H., Petkova E., Babulas V., et al. Am. J. Psychiatry 2004, 161(5):889-895. (2004/05/04).
66. Ashdown H., Dumont Y., Ng M., Poole S., Boksa P., Luheshi G.N. Mol. Psychiatry 2006, 11(1):47-55. (2005/09/29).
67. Smith S.E., Li J., Garbett K., Mirnics K., Patterson P.H. J. Neurosci. 2007, 27(40):10695-10702. (2007/10/05).
68. Meyer U., Feldon J., Yee B.K. Schizophr. Bull. 2009, 35(5):959-972. (2008/04/15).
69. Gilmore J.H., Fredrik Jarskog L., Vadlamudi S., Lauder J.M. Neuropsychopharmacology 2004, 29(7):1221-1229. (2004/04/16).
70. Steptoe A., Willemsen G., Owen N., Flower L., Mohamed-Ali V. Clin. Sci. (Lond.) 2001, 101(2):185-192. (2001/07/28).
71. Lederbogen F., Kirsch P., Haddad L., Streit F., Tost H., Schuch P., et al. Nature 2011, 474(7352):498-501. (2011/06/24).
72. Lander E.S., Linton L.M., Birren B., Nusbaum C., Zody M.C., Baldwin J., et al. Nature 2001, 409(6822):860-921.
73. McPherson J.D., Marra M., Hillier L., Waterston R.H., Chinwalla A., Wallis J., et al. Nature 2001, 409(6822):934-941. (2001/03/10).
74. Sun H., Kennedy P.J., Nestler E.J. Neuropsychopharmacology 2013, 38(1):124-137. (2012/06/14).
75. Antequera F. Cell. Mol. Life Sci. 2003, 60(8):1647-1658. (2003/09/25).
76. Lewis D.A., Glantz L.A., Pierri J.N., Sweet R.A. Ann. N. Y. Acad. Sci. 2003, 1003:102-112. (2003/12/20).
77. Glantz L.A., Lewis D.A. Arch. Gen. Psychiatry 2000, 57(1):65-73. (2000/01/13).
78. Lewis D.A., Curley A.A., Glausier J.R., Volk D.W. Trends Neurosci. 2012, 35(1):57-67. (2011/12/14).
79. Lewis D.A., Hashimoto T., Volk D.W. Nat. Rev. Neurosci. 2005, 6(4):312-324.
80. Akbarian S., Huang H.S. Brain Res. Rev. 2006, 52(2):293-304. (2006/06/09).
81. Huang H.S., Akbarian S. PLoS ONE 2007, 2(8):e809. (2007/08/30).
82. Dong E., Nelson M., Grayson D.R., Costa E., Guidotti A. Proc. Natl. Acad. Sci. U. S. A. 2008, 105(36):13614-13619. (2008/09/02).
83. Guidotti A., Auta J., Davis J.M., Di-Giorgi-Gerevini V., Dwivedi Y., Grayson D.R., et al. Arch. Gen. Psychiatry 2000, 57(11):1061-1069. (2000/11/14).
84. Tochigi M., Iwamoto K., Bundo M., Komori A., Sasaki T., Kato N., et al. Biol. Psychiatry 2008, 63(5):530-533. (2007/09/18).
85. Abdolmaleky H.M., Cheng K.H., Russo A., Smith C.L., Faraone S.V., Wilcox M., et al. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2005, 134B(1):60-66. (2005/02/18).
86. Dong E., Guidotti A., Grayson D.R., Costa E. Proc. Natl. Acad. Sci. U. S. A. 2007, 104(11):4676-4681. (2007/03/16).
87. Simonini M.V., Camargo L.M., Dong E., Maloku E., Veldic M., Costa E., et al. Proc. Natl. Acad. Sci. U. S. A. 2006, 103(5):1587-1592. (2006/01/25).
88. Zhang A.P., Yu J., Liu J.X., Zhang H.Y., Du Y.Y., Zhu J.D., et al. Schizophr. Res. 2007, 90(1-3):97-103. (2007/01/09).
89. Pryce C.R., Ruedi-Bettschen D., Dettling A.C., Weston A., Russig H., Ferger B., et al. Neurosci. Biobehav. Rev. 2005, 29(4-5):649-674. (2005/06/01).
90. Sanchez M.M., Ladd C.O., Plotsky P.M. Dev. Psychopathol. 2001, 13(3):419-449. (2001/08/29).
91. de Kloet E.R., Sibug R.M., Helmerhorst F.M., Schmidt M.V. Neurosci. Biobehav. Rev. 2005, 29(2):271-281. (2005/04/07).
92. Weaver I.C., Cervoni N., Champagne F.A., D'Alessio A.C., Sharma S., Seckl J.R., et al. Nat. Neurosci. 2004, 7(8):847-854. (2004/06/29).
93. Uchida S., Hara K., Kobayashi A., Otsuki K., Yamagata H., Hobara T., et al. Neuron 2011, 69(2):359-372. (2011/01/26).
94. Niwa M., Jaaro-Peled H., Tankou S., Seshadri S., Hikida T., Matsumoto Y., et al. Science 2013, 339(6117):335-339. (2013/01/19).
95. Murgatroyd C., Patchev A.V., Wu Y., Micale V., Bockmuhl Y., Fischer D., et al. Nat. Neurosci. 2009, 12(12):1559-1566. (2009/11/10).
96. Branco M.R., Ficz G., Reik W. Nat. Rev. Genet. 2012, 13(1):7-13. (2011/11/16).
97. Sommer I.E., Slotema C.W., Daskalakis Z.J., Derks E.M., Blom J.D., van der Gaag M. Schizophr. Bull. 2012, 38(4):704-714. (2012/03/01).
98. Tsankova N.M., Kumar A., Nestler E.J. J. Neurosci. 2004, 24(24):5603-5610. (2004/06/18).
99. Li J., Guo Y., Schroeder F.A., Youngs R.M., Schmidt T.W., Ferris C., et al. J. Neurochem. 2004, 90(5):1117-1131. (2004/08/18).
100. Swanson C.J., Bures M., Johnson M.P., Linden A.M., Monn J.A., Schoepp D.D. Nat. Rev. Drug Discov. 2005, 4(2):131-144.
101. Marek G.J. Curr. Opin. Pharmacol. 2004, 4(1):18-22.
102. Krystal J.H., Mathew S.J., D'Souza D.C., Garakani A., Gunduz-Bruce H., Charney D.S. CNS Drugs 2010, 24(8):669-693. (2010/07/28).
103. Moreno J.L., Sealfon S.C., Gonzalez-Maeso J. Cell. Mol. Life Sci. 2009, 66(23):3777-3785. (2009/08/27).
104. Dwyer J.M., Lepack A.E., Duman R.S. J. Mol. Psychiatry 2013, 1(1):15. (2013/01/01).
105. Pilc A., Wieronska J.M., Skolnick P. Biol. Psychiatry 2013, 73(12):1125-1132. (2013/03/05).
106. Muguruza C., Miranda-Azpiazu P., Diez-Alarcia R., Morentin B., Gonzalez-Maeso J., Callado L.F., et al. Neuropharmacology 2014, 86:311-318. (2014/08/26).
107. Nasca C., Xenos D., Barone Y., Caruso A., Scaccianoce S., Matrisciano F., et al. Proc. Natl. Acad. Sci. U. S. A. 2013, 110(12):4804-4809. (2013/02/06).
108. Cuccurazzu B., Bortolotto V., Valente M.M., Ubezio F., Koverech A., Canonico P.L., et al. Neuropsychopharmacology 2013, 38:2220-2230. (2013/05/15).
109. Fraga M.F., Ballestar E., Paz M.F., Ropero S., Setien F., Ballestar M.L., et al. Proc. Natl. Acad. Sci. U. S. A. 2005, 102(30):10604-10609. (2005/07/13).
110. Graff J., Tsai L.H. Nat. Rev. Neurosci. 2013, 14(2):97-111. (2013/01/18).
111. Ekwall K. Trends Genet. 2005, 21(11):608-615. (2005/09/13).
112. Couture J.F., Trievel R.C. Curr. Opin. Struct. Biol. 2006, 16(6):753-760. (2006/10/31).
113. Abel T., Zukin R.S. Curr. Opin. Pharmacol. 2008, 8(1):57-64. (2008/01/22).
114. Scandura J.M., Roboz G.J., Moh M., Morawa E., Brenet F., Bose J.R., et al. Blood 2011, 118(6):1472-1480. (2011/05/27).
115. Weaver I.C., Meaney M.J., Szyf M. Proc. Natl. Acad. Sci. U. S. A. 2006, 103(9):3480-3485. (2006/02/18).
116. Guan J.S., Haggarty S.J., Giacometti E., Dannenberg J.H., Joseph N., Gao J., et al. Nature 2009, 459(7243):55-60. (2009/05/09).
117. Kurita M., Holloway T., Garcia-Bea A., Kozlenkov A., Friedman A.K., Moreno J.L., et al. Nat. Neurosci. 2012, 15(9):1245-1254. (2012/08/07).
118. Kurita M., Holloway T., Gonzalez-Maeso J. Expert. Rev. Neurother. 2013, 13(1):1-3. (2012/12/21).
119. Nalivaeva N.N., Belyaev N.D., Turner A.J. Trends Pharmacol. Sci. 2009, 30(10):509-514. (2009/09/19).
120. Casey D.E., Daniel D.G., Wassef A.A., Tracy K.A., Wozniak P., Sommerville K.W. Neuropsychopharmacology 2003, 28(1):182-192. (2002/12/24).
121. Citrome L., Casey D.E., Daniel D.G., Wozniak P., Kochan L.D., Tracy K.A. Psychiatr. Serv. 2004, 55(3):290-294. (2004/03/06).
122. Kelly D.L., Conley R.R., Feldman S., Yu Y., McMahon R.P., Richardson C.M. Psychiatry Q. 2006, 77(1):81-95. (2006/01/07).
123. Suzuki T., Uchida H., Takeuchi H., Nakajima S., Nomura K., Tanabe A., et al. Hum. Psychopharmacol. 2009, 24(8):628-638. (2009/12/01).
124. Lee M.P. Ann. N. Y. Acad. Sci. 2003, 983:101-109. (2003/05/02).
125. Kundaje A., Meuleman W., Ernst J., Bilenky M., Yen A., Heravi-Moussavi A., et al. Nature 2015, 518(7539):317-330. (2015/02/20).